Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin (Q43249113)

17 November 2017

title

Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin (English)

1 reference

17 November 2017

main subject

multiple drug resistance

1 reference

Enterococcus faecium

1 reference

Amanda C Schutt

1

1 reference

17 November 2017

Nicole M Bohm

series ordinal

2

1 reference

17 November 2017

language of work or name

English

0 references

publication date

3 November 2009

1 reference

Annals of Pharmacotherapy

17 November 2017

published in

1 reference

17 November 2017

volume

43

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

2108-2112

1 reference

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial

17 November 2017

cites work

1 reference

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria

21 January 2018

1 reference

Once-daily dosing in dogs optimizes daptomycin safety

21 January 2018

1 reference

Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations

21 January 2018

1 reference

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vi

21 January 2018

1 reference

Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms

21 January 2018

1 reference

Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects

21 January 2018

1 reference

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

21 January 2018

1 reference

Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model

21 January 2018

1 reference

Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program

21 January 2018

1 reference

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.

21 January 2018

1 reference

Daptomycin in the treatment of patients with infective endocarditis: experience from a registry

21 January 2018

1 reference

Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster

21 January 2018

1 reference

Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients

21 January 2018

1 reference

Tigecycline: a critical analysis

21 January 2018

1 reference

In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin

21 January 2018

1 reference

Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci

21 January 2018

1 reference

Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves

21 January 2018

1 reference

Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M324

1 reference

17 November 2017

1 reference